Shanghai Kaibao Pharmaceutical's wholly-owned subsidiary obtained a drug registration certificate.

Shanghai Kaibao Pharmaceutical (300039.SZ) announced that its wholly-owned subsidiary, Shanghai Kaibao Pharmaceutical Xinyi (Xinxiang) Pharmaceutical Co., Ltd. (referred to as the "Subsidiary"), recently received the Drug Registration Certificate for Dossotea Tablets issued by the National Medical Products Administration. Dossotea Tablets are used for bronchial asthma, wheezing chronic bronchitis, and other respiratory difficulties caused by bronchial spasms.